LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Abbott Laboratories Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$174.02M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.12% | -2.18K shares | -21.62M | $96.76 | 1.79M |
| Q2 2022 | share | Decrease | -0.46% | -8.36K shares | -18.47M | $108.65 | 1.80M |
| Q1 2022 | share | Decrease | -1.28% | -23.51K shares | -43.79M | $118.36 | 1.80M |
| Q4 2021 | share | Decrease | -0.06% | -1.01K shares | 41.31M | $141 | 1.83M |
| Q3 2021 | share | Increase | +0.18% | 3.20K shares | 4.40M | $117.68 | 1.83M |
| Q2 2021 | share | Increase | +1.40% | 25.29K shares | -4.12M | $115.05 | 1.83M |
| Q1 2021 | share | Decrease | -1.27% | -23.16K shares | 16.14M | $118.49 | 1.80M |
| Q4 2020 | share | Increase | +0.21% | 3.92K shares | 1.63M | $107.81 | 1.82M |
| Q3 2020 | share | Decrease | -0.38% | -6.89K shares | 31.11M | $106.81 | 1.82M |
| Q2 2020 | share | Decrease | -0.90% | -16.65K shares | 21.61M | $89.39 | 1.83M |
| Q1 2020 | share | Decrease | -1.13% | -21.10K shares | -16.52M | $76.84 | 1.84M |
| Q4 2019 | share | Decrease | -0.38% | -7.16K shares | 5.36M | $84.23 | 1.86M |
| Q3 2019 | share | Decrease | -1.03% | -19.43K shares | -2.44M | $80.81 | 1.87M |
| Q2 2019 | share | Decrease | -1.84% | -35.46K shares | 5.05M | $80.92 | 1.89M |
| Q1 2019 | share | Decrease | -3.41% | -68.10K shares | 9.76M | $76.6 | 1.93M |
| Q4 2018 | share | Decrease | -1.85% | -37.68K shares | -4.82M | $68.98 | 1.99M |
| Q3 2018 | share | Decrease | -1.24% | -25.62K shares | 23.63M | $69.69 | 2.03M |
| Q2 2018 | share | Decrease | -2.10% | -44.29K shares | -448K | $57.68 | 2.06M |
| Q1 2018 | share | Decrease | -0.60% | -12.70K shares | 5.28M | $56.4 | 2.10M |
| Q4 2017 | share | Increase | +0.32% | 6.66K shares | 8.21M | $53.46 | 2.11M |
| Q3 2017 | share | Increase | +1.02% | 21.33K shares | 9.88M | $49.74 | 2.11M |
| Q2 2017 | share | Decrease | -1.68% | -35.78K shares | 8.38M | $45.07 | 2.09M |
| Q1 2017 | share | Increase | +1.92% | 40.10K shares | 14.30M | $40.93 | 2.12M |
| Q4 2016 | share | Increase | +5.12% | 101.69K shares | -3.79M | $35.17 | 2.08M |
| Q3 2016 | share | Increase | +1.48% | 28.98K shares | 7.05M | $38.48 | 1.98M |
| Q2 2016 | share | Increase | +13.31% | 229.76K shares | 4.68M | $35.55 | 1.95M |
| Q1 2016 | share | Increase | +9.36% | 147.72K shares | 1.31M | $37.6 | 1.72M |